成人VR视频

The institute that developed the 鈥淢ontreal Procedure鈥 continues to be on the cutting edge

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the 鈥淢ontreal Procedure,鈥 which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).

Classified as: Andrea Bernasconi, Eva Andermann, Francois Dubeau, Birgit Frauscher, Eliane Kobayashi, Jeffrey Hall, Dr Olivier, Massimo Avoli, Neda Ladbon-Bernasconi, Boris Bernhardt, Jean Gotman
Published on: 26 Mar 2018

2017 Qu茅bec Science Discovery of the Year Award goes to the cancer-detection probe developed by听Kevin Petrecca and Fr茅d茅ric Leblond

Qu茅bec Science magazine鈥檚 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.

Classified as: Kevin Petrecca, Frederic Leblond, cancer probe, raman spectroscopy, Quebec Science, brain cancer, brain tumour, Jason Karamchandani
Published on: 19 Mar 2018

Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge

The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.

Classified as: Neuro XXceptional, women in science, Heidi McBride, Lesley Fellows, Brenda Milner
Published on: 8 Mar 2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Classified as: Thermo Fisher, open science, ALS, Parkinson's disease, ataxia, reagrents, Peter McPherson
Published on: 5 Mar 2018

You鈥檙e about to turn 60, and you鈥檙e fretting. Your mother has had Alzheimer鈥檚 disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer鈥檚, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

Classified as: Alzheimer's disease, Alzheimer's, Sylvia Villeneuve
Published on: 26 Feb 2018

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer鈥檚 disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Classified as: neuroinformatics, Alan Evans, CONP, Canadian Open Neuroscience Platform, Brain Canada, Guy Rouleau
Published on: 19 Feb 2018

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain鈥檚 anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer鈥檚 disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Classified as: Alzheimer's disease, AD, MRI, Christine Tardif, Mallar Chakravarty, Douglas Institute
Published on: 19 Dec 2017

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson鈥檚 disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.

Classified as: open science, MNI, Guy Rouleau
Published on: 6 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Thomas Durcan, Edward Fon, Guy Rouleau
Published on: 4 Dec 2017

Senate of Canada recognizes outstanding contributions to the community听

The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer鈥檚 disease and palliative care research. He was nominated by , a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the 成人VR视频 School of Social Work.

Classified as: Alan Evans
Category:
Published on: 27 Nov 2017

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million听

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million. 听

Classified as: Heather Durham, Stefano Stifani, josephine nalbantoglu
Published on: 24 Nov 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Classified as: autism, Azrieli Centre for Autism Research, Azrieli Foundation, Guy Rouleau, ACAR Stories
Published on: 23 Oct 2017

A Brilliant Night has donated a total of $1.6 million since 2015

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

Classified as: a brilliant night, Kevin Petrecca, brain cancer, brain tumour
Published on: 10 Oct 2017

Research shows how the brain鈥檚 motor signals sharpen our ability to decipher complex sound flows

Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.

Classified as: Motor signals, Sound perception, Benjamin Morillon, Sylvain Baillet
Published on: 5 Oct 2017

Pages

Back to top